Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

Post by StockHawk1on Dec 23, 2021 3:25pm
63 Views
Post# 34259022

Has $ASEP hit its bottom?

Has $ASEP hit its bottom?

I think one of my biotech picks may have reached its bottom and I'm feeling bullish about it.  


Asep Medical Holdings Inc ( $ASEP.C ) is addressing antibiotic failure and sepsis treatment in two main ways:

-through peptide technology

- and early sepsis detection tech 


Sepsis occurred in 49M people globally in 2017 ALONE, and currently, antibiotics are the go-to treatment for it. 


For 23% of these patients, antibiotics fail which leads to 11 million deaths (19.7% of all deaths in 2017 annually. 


Early detection of sepsis allows doctors to make better informed life-saving decisions earlier which will add to the efficacy of antibiotics. 


$ASEP's tech includes a novel diagnostic tool that detects the dysfunctional immune response that underlies the most severe forms of sepsis. 


The company is also developing peptide tech which allows antibiotics better penetrate the bacteria that causes sepsis and other infections. 


IMO now might be a good time to invest because clinical testing their tech is already underway for the sepsis detection tech and the company intends to file for  regulatory approval within the next 6-9 months.


I think that once we could see these filings and eventual approval as huge catalysis for $ASEP. 


 Additionally, I think that we might be seeing the bottom $ASEP's price dip and things could get bullish again as investors realize the value and demand for this biotech. 


Right now $ASEP is trading at $0.50 (stable today)


https://asepmedical.com/investors/

 
<< Previous
Bullboard Posts
Next >>